newsfilter
← Latest News
PR Newswire·

Innocan Pharma Announces the Addition of Dr. Joseph V. Pergolizzi, Jr., M.D. to its Advisory Board

HERZLIYA, Israel and CALGARY, AB, Sept. 15, 2023 /CNW/ -- Innocan Pharma Corporation (CSE:INNO) (FSE: IP4) (OTCQB:INNPF) (the "Company" or "Innocan") a pioneering pharmaceutical technology company